For condition: Hidradenitis Suppurativa
Hidradenitis Suppurativa Study (24 Weeks)
Study Summary
Who Can Participate?
People aged 12 to 75 with hidradenitis suppurativa may participate.
Inclusion Criteria
• Have a diagnosis of HS for at least 6 months
• Have a total estimated treatment BSA > 20%
• Agree to NOT use topical or systemic antibiotics for treatment of HS
• Agree to NOT use topical antiseptics, including washes and leave-on products, with ingredients such as chlorhexidine gluconate, povidone iodine, sodium hypochlorite, diluted bleach, or benzoyl peroxide on the areas affected by HS lesions
Participant Information
• Participate and receive study treatment at no cost
• Regular visits with study doctors who specialise in treating hidradenitis suppurativa (up to 9 visits)
• Will receive an investigative topical treatment (study drug)
• Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
• Up to approximately 24 weeks
For more information about this trial, please visit ClinicalTrials.gov
